PURPOSE: To describe the phenotype and genotype of patients with a diagnosis of oligocone trichromacy (OT). METHODS: Six unrelated patients had a detailed ophthalmic examination including color vision testing, a Goldmann visual field test, fundus photography, and full-field electroretinography (ffERG). Five patients also underwent multifocal (mf)ERG, autofluorescence recording, and optical coherence tomography (OCT). Genetic analysis included sequencing of all coding regions and flanking introns of CNGA3, CNGB3, GNAT2, KCNV2, and PDE6C. RESULTS: All patients had subnormal visual acuity, a history of congenital nystagmus, and subjectively normal or near-normal color vision; five patients reported photophobia. Clinical examinations revealed largely normal fundi, normal Goldmann visual field results with the IV/4e target, and normal color discrimination or mild color vision deficiency. Electrophysiological investigations showed either complete absence of recordable cone responses or severely reduced amplitudes. All retinal layers were identifiable by OCT, which also showed thinning of the peripheral retina. Genetic analysis revealed two causative CNGB3 mutations in one patient and single heterozygous mutations of unknown significance in CNGB3 and PDE6C in two other patients. CONCLUSIONS: Oligocone trichromacy is a heterogeneous condition with respect to both phenotypic appearance and genetic background. The finding of mutations in genes known to be involved in complete and incomplete achromatopsia supports the notion that some forms of OT is an extreme form of incomplete achromatopsia with preferential loss of peripheral cones.
PURPOSE: To describe the phenotype and genotype of patients with a diagnosis of oligocone trichromacy (OT). METHODS: Six unrelated patients had a detailed ophthalmic examination including color vision testing, a Goldmann visual field test, fundus photography, and full-field electroretinography (ffERG). Five patients also underwent multifocal (mf)ERG, autofluorescence recording, and optical coherence tomography (OCT). Genetic analysis included sequencing of all coding regions and flanking introns of CNGA3, CNGB3, GNAT2, KCNV2, and PDE6C. RESULTS: All patients had subnormal visual acuity, a history of congenital nystagmus, and subjectively normal or near-normal color vision; five patients reported photophobia. Clinical examinations revealed largely normal fundi, normal Goldmann visual field results with the IV/4e target, and normal color discrimination or mild color vision deficiency. Electrophysiological investigations showed either complete absence of recordable cone responses or severely reduced amplitudes. All retinal layers were identifiable by OCT, which also showed thinning of the peripheral retina. Genetic analysis revealed two causative CNGB3 mutations in one patient and single heterozygous mutations of unknown significance in CNGB3 and PDE6C in two other patients. CONCLUSIONS: Oligocone trichromacy is a heterogeneous condition with respect to both phenotypic appearance and genetic background. The finding of mutations in genes known to be involved in complete and incomplete achromatopsia supports the notion that some forms of OT is an extreme form of incomplete achromatopsia with preferential loss of peripheral cones.
Authors: Jianhua Xu; Lynsie M Morris; Stylianos Michalakis; Martin Biel; Steven J Fliesler; David M Sherry; Xi-Qin Ding Journal: Invest Ophthalmol Vis Sci Date: 2012-03-01 Impact factor: 4.799
Authors: Michel Michaelides; Jungtae Rha; Elise W Dees; Rigmor C Baraas; Melissa L Wagner-Schuman; John D Mollon; Adam M Dubis; Mette K G Andersen; Thomas Rosenberg; Michael Larsen; Anthony T Moore; Joseph Carroll Journal: Invest Ophthalmol Vis Sci Date: 2011-07-01 Impact factor: 4.799
Authors: Jonathan Aboshiha; Vy Luong; Jill Cowing; Adam M Dubis; James W Bainbridge; Robin R Ali; Andrew R Webster; Anthony T Moore; Frederick W Fitzke; Michel Michaelides Journal: Invest Ophthalmol Vis Sci Date: 2014-08-28 Impact factor: 4.799
Authors: Jonathan Aboshiha; Adam M Dubis; Joseph Carroll; Alison J Hardcastle; Michel Michaelides Journal: Br J Ophthalmol Date: 2015-03-13 Impact factor: 4.638
Authors: Rupert W Strauss; Adam M Dubis; Robert F Cooper; Rola Ba-Abbad; Anthony T Moore; Andrew R Webster; Alfredo Dubra; Joseph Carroll; Michel Michaelides Journal: Am J Ophthalmol Date: 2015-09-03 Impact factor: 5.258